|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SHEFFIELD PHARMACEUTICALS INC, 10-Q, 2000-11-03 |
Next: PEROT SYSTEMS CORP, 10-Q, 2000-11-03 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED FINANCIAL STATEMENTS FOR THE QUARTER ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 1,644,434
<SECURITIES> 921,091
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 2,934,799
<PP&E> 659,023
<DEPRECIATION> 392,673
<TOTAL-ASSETS> 3,467,426
<CURRENT-LIABILITIES> 824,872
<BONDS> 0
0
319
<COMMON> 281,053
<OTHER-SE> (976,058)
<TOTAL-LIABILITY-AND-EQUITY> 3,467,426
<SALES> 0
<TOTAL-REVENUES> 291,784
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 4,584,394
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 164,424
<INCOME-PRETAX> (4,159,041)
<INCOME-TAX> 0
<INCOME-CONTINUING> (4,159,041)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (4,159,041)
<EPS-BASIC> (.15)
<EPS-DILUTED> (.15)
</TABLE>
|
|